Lexicon Pharms Inc Drug Patent Portfolio

Lexicon Pharms Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lexicon Pharms Inc News

LXRX Shares Rise Following NVO's Launch of Phase I Trial for Collaborative Obesity Medication - TradingView

24 Mar, 2026

Novo Nordisk Pursues Expansion Beyond Its Leading Medications with New Trial for Obesity Treatment

24 Mar, 2026

See More